Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, New Zealand.
FEBS Lett. 2019 Mar;593(5):475-486. doi: 10.1002/1873-3468.13330. Epub 2019 Feb 7.
There is a paucity of information on the unique components that pathogens use to form respiratory chains. It is not known why mycobacteria encode multiple succinate dehydrogenases (SDHs) to perform menaquinone-linked succinate oxidation, a thermodynamically unfavorable reaction (ΔG° = +21 kJ·mol ). In other bacteria, specific di-heme SDHs overcome this using the proton motive force. It is unknown if this holds true in mycobacteria. Here, succinate dehydrogenase 1 (Sdh1) from Mycobacterium smegmatis was purified and found to not contain heme cofactors. Proteoliposomes, containing Sdh1, are active with coenzyme Q (K ~ 12 μm), are competitively inhibited by menaquinone (K ~ 25 μm) and do not generate or consume electrochemical gradients. Sdh1 may use higher potential quinones in vivo and forms a novel SDH class, which we term 'Type F'.
有关病原体用于形成呼吸链的独特成分的信息很少。目前尚不清楚为什么分枝杆菌编码多种琥珀酸脱氢酶(SDH)来进行menaquinone 连接的琥珀酸氧化,这是一种热力学上不利的反应(ΔG°= +21 kJ·mol)。在其他细菌中,特定的双血红素 SDH 利用质子动力势克服了这一问题。目前尚不清楚这是否适用于分枝杆菌。在这里,从耻垢分枝杆菌中纯化得到的琥珀酸脱氢酶 1(Sdh1),并发现它不含有血红素辅因子。含有 Sdh1 的蛋白脂质体与辅酶 Q(K 约为 12 µm)具有活性,被menaquinone(K 约为 25 µm)竞争性抑制,并且不产生或消耗电化学梯度。Sdh1 可能在体内使用更高电位的醌,并形成一种新型的 SDH 类,我们称之为“Type F”。